Edition:
United States

Bristol-Myers Squibb Co (BMY)

BMY on New York Consolidated

56.71USD
20 Jul 2018
Change (% chg)

$0.17 (+0.30%)
Prev Close
$56.54
Open
$56.60
Day's High
$56.88
Day's Low
$56.42
Volume
4,779,148
Avg. Vol
7,982,471
52-wk High
$70.05
52-wk Low
$49.96

Chart for

About

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small... (more)

Overall

Beta: 0.99
Market Cap(Mil.): $92,416.80
Shares Outstanding(Mil.): 1,634.54
Dividend: 0.40
Yield (%): 2.82

Financials

  BMY Industry Sector
P/E (TTM): 24.42 29.12 33.34
EPS (TTM): 2.32 -- --
ROI: 16.11 13.60 13.18
ROE: 28.04 15.30 15.09

RPT-UPDATE 2-Roche takes Tecentriq hit on survival data

ZURICH, July 19 Roche's hopes of clinching more of the lung cancer treatment market with its Tecentriq immunotherapy had a major setback on Thursday, when a trial failed to deliver survival data the Swiss drugmaker needs to challenge rival Merck.

Jul 19 2018

Roche takes Tecentriq hit on survival data

ZURICH Roche's hopes of clinching more of the lung cancer treatment market with its Tecentriq immunotherapy had a major setback on Thursday, when a trial failed to deliver survival data the Swiss drugmaker needs to challenge rival Merck.

Jul 19 2018

UPDATE 2-Roche takes Tecentriq hit on survival data

* Swiss drugmaker says data may come in 2019 (Adds shares, comments from analysts and background)

Jul 19 2018

Italy - Factors to watch on July 6

The following factors could affect Italian markets on Friday.

Jul 06 2018

Exclusive: BMS hires banks for 1 billion euro-plus sale of French OTC drug unit - sources

LONDON U.S. pharmaceuticals giant Bristol-Myers Squibb has hired two banks to find a buyer for its French over-the-counter (OTC) drugs business, which could be valued at more than 1 billion euros in a potential deal, sources familiar with the matter told Reuters.

Jul 05 2018

Australia shares end down, commodities drag; NZ finishes at record

* Commodity stocks lead losses, banks rise as CBA extends gains

Jun 05 2018

The next battleground after SCOTUS' BMS ruling? Class actions, defense lawyers say

Product liability defense lawyers expect the U.S. Supreme Court to eventually look at making explicit that the restrictions it placed on where plaintiffs can bring injury claims in Bristol-Myers Squibb v. Superior Court of California also apply to class actions.

Jun 04 2018

Tech rally helps Wall Street push higher, Nasdaq has record close

NEW YORK Wall Street's three major indexes rose on Monday, led by a rally in tech stocks, pushing the Nasdaq to a record closing high as investors bet on a continuation of strong economic growth, while falling oil prices weighed on the energy sector. | Video

Jun 04 2018

US STOCKS-Tech rally helps Wall St push higher, Nasdaq has record close

* Indexes gain: Dow 0.72 pct, S&P 0.45 pct, Nasdaq 0.69 pct (Updates to close, adds commentary)

Jun 04 2018

US STOCKS-Technology rally helps Wall Street push higher

* Indexes gain: Dow 0.66 pct, S&P 0.41 pct, Nasdaq 0.57 pct (Updates to late afternoon, adds commentary, changes byline, adds New York dateline)

Jun 04 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $125.85 -0.09
Pfizer Inc. (PFE.N) $37.33 -0.03
Merck & Co., Inc. (MRK.N) $62.52 +0.01
Sanofi SA (SASY.PA) €72.36 +0.25
AstraZeneca plc (AZN.L) 5,589.00 -20.00
GlaxoSmithKline plc (GSK.L) 1,549.80 -8.20
Eli Lilly And Co (LLY.N) $88.47 -0.96
Roche Holding Ltd. (ROG.S) CHF234.00 +2.05
Roche Holding Ltd. (RO.S) CHF238.60 +2.80

Earnings vs. Estimates